X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ACTAVIS (US) - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   ACTAVIS
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-18
ACTAVIS
Dec-14
PIRAMAL ENTERPRISES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,08319,451-   
Low Rs1,90211,864-   
Sales per share (Unadj.) Rs589.73,502.5-  
Earnings per share (Unadj.) Rs284.0-437.1-  
Cash flow per share (Unadj.) Rs310.5321.3-  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs1,467.07,596.8-  
Shares outstanding (eoy) m180.27265.90-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x4.24.5 94.5%   
Avg P/E ratio x8.8-35.8 -24.5%  
P/CF ratio (eoy) x8.048.7 16.5%  
Price / Book Value ratio x1.72.1 82.4%  
Dividend payout %8.80-   
Avg Mkt Cap Rs m449,3324,163,324 10.8%   
No. of employees `0006.821.6 31.7%   
Total wages/salary Rs m19,8810-   
Avg. sales/employee Rs Th15,535.643,116.7 36.0%   
Avg. wages/employee Rs Th2,905.40-   
Avg. net profit/employee Rs Th7,482.5-5,380.5 -139.1%   
INCOME DATA
Net Sales Rs m106,310931,321 11.4%  
Other income Rs m2,595-2,324 -111.7%   
Total revenues Rs m108,906928,996 11.7%   
Gross profit Rs m51,599119,641 43.1%  
Depreciation Rs m4,773201,665 2.4%   
Interest Rs m29,78329,376 101.4%   
Profit before tax Rs m19,638-113,724 -17.3%   
Minority Interest Rs m2,8010-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-8,342 0.0%   
Tax Rs m-28,764-5,847 492.0%   
Profit after tax Rs m51,203-116,219 -44.1%  
Gross profit margin %48.512.8 377.8%  
Effective tax rate %-146.55.1 -2,849.1%   
Net profit margin %48.2-12.5 -386.0%  
BALANCE SHEET DATA
Current assets Rs m118,154490,687 24.1%   
Current liabilities Rs m462,260357,855 129.2%   
Net working cap to sales %-323.714.3 -2,269.4%  
Current ratio x0.31.4 18.6%  
Inventory Days Days2758 45.8%  
Debtors Days Days4766 70.2%  
Net fixed assets Rs m113,727113,724 100.0%   
Share capital Rs m3610-   
"Free" reserves Rs m264,0930-   
Net worth Rs m264,4542,020,000 13.1%   
Long term debt Rs m242,2061,058,520 22.9%   
Total assets Rs m726,8343,701,996 19.6%  
Interest coverage x1.7-2.9 -57.8%   
Debt to equity ratio x0.90.5 174.8%  
Sales to assets ratio x0.10.3 58.1%   
Return on assets %11.1-2.3 -475.0%  
Return on equity %19.4-5.8 -336.5%  
Return on capital %10.3-3.0 -342.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,8130-   
CASH FLOW
From Operations Rs m-159,666159,926 -99.8%  
From Investments Rs m-17,677-382,924 4.6%  
From Financial Activity Rs m186,503215,148 86.7%  
Net Cashflow Rs m9,364-7,850 -119.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.3 Rs / USD

Compare PIRAMAL ENTERPRISES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PIRAMAL ENTERPRISES With: NATCO PHARMA  GLENMARK PHARMA  CIPLA  J.B.CHEMICALS  STRIDES PHARMA SCIENCE  



Today's Market

Sensex Trades in Red; IT & Metal Stocks Drag(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.7% while the Hang Seng is down 0.2%.

Related Views On News

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY19); Net Profit Down 152.5% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 1 bn (down 152.5% YoY). Sales on the other hand came in at Rs 29 bn (up 28.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Nov 21, 2018 09:55 AM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS